STAAR Surgical Company (STAA)
USD 15.09
(-6.51%)
USD 15.09
(-6.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -147.2 Million USD | -165.51% |
| 2022 | -55.44 Million USD | 66.93% |
| 2021 | -167.64 Million USD | -18.35% |
| 2020 | -141.65 Million USD | -28.28% |
| 2019 | -110.42 Million USD | -12.07% |
| 2018 | -98.54 Million USD | -702.9% |
| 2017 | -12.27 Million USD | -70.96% |
| 2016 | -7.17 Million USD | 17.26% |
| 2015 | -8.67 Million USD | -8.52% |
| 2014 | -7.99 Million USD | 55.02% |
| 2013 | -17.77 Million USD | -22.52% |
| 2012 | -14.5 Million USD | -18.13% |
| 2011 | -12.28 Million USD | -141.66% |
| 2010 | -5.08 Million USD | -328.3% |
| 2009 | 2.22 Million USD | -43.59% |
| 2008 | 3.94 Million USD | 185.86% |
| 2007 | -4.59 Million USD | -2.16% |
| 2006 | -4.49 Million USD | 59.22% |
| 2005 | -11.03 Million USD | -832.54% |
| 2004 | -1.18 Million USD | 72.72% |
| 2003 | -4.33 Million USD | -189.66% |
| 2002 | 4.83 Million USD | -34.32% |
| 2001 | 7.36 Million USD | 296.48% |
| 2000 | 1.85 Million USD | -85.82% |
| 1999 | 13.1 Million USD | 72.37% |
| 1998 | 7.6 Million USD | 590.91% |
| 1997 | 1.1 Million USD | -56.0% |
| 1996 | 2.5 Million USD | 78.57% |
| 1995 | 1.4 Million USD | 275.0% |
| 1994 | -800 Thousand USD | -500.0% |
| 1993 | 200 Thousand USD | 122.22% |
| 1992 | -900 Thousand USD | 25.0% |
| 1991 | -1.2 Million USD | -170.59% |
| 1990 | 1.7 Million USD | -85.47% |
| 1989 | 11.7 Million USD | 19.39% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -124 Million USD | 20.77% |
| 2024 Q2 | -156.5 Million USD | 16.9% |
| 2024 Q1 | -188.32 Million USD | -27.94% |
| 2023 Q4 | -147.2 Million USD | -60.81% |
| 2023 FY | -147.2 Million USD | -165.51% |
| 2023 Q3 | -91.53 Million USD | -47.15% |
| 2023 Q2 | -62.2 Million USD | -7.14% |
| 2023 Q1 | -58.06 Million USD | -4.73% |
| 2022 Q3 | -99.31 Million USD | 42.07% |
| 2022 Q2 | -171.44 Million USD | -6.35% |
| 2022 Q4 | -55.44 Million USD | 44.18% |
| 2022 Q1 | -161.2 Million USD | 3.84% |
| 2022 FY | -55.44 Million USD | 66.93% |
| 2021 Q4 | -167.64 Million USD | 2.99% |
| 2021 FY | -167.64 Million USD | -18.35% |
| 2021 Q1 | -152.21 Million USD | -7.46% |
| 2021 Q2 | -160.27 Million USD | -5.29% |
| 2021 Q3 | -172.81 Million USD | -7.82% |
| 2020 FY | -141.65 Million USD | -28.28% |
| 2020 Q4 | -141.65 Million USD | -19.33% |
| 2020 Q3 | -118.7 Million USD | -9.19% |
| 2020 Q2 | -108.71 Million USD | -5.85% |
| 2020 Q1 | -102.7 Million USD | 7.0% |
| 2019 Q4 | -110.42 Million USD | -8.29% |
| 2019 FY | -110.42 Million USD | -12.07% |
| 2019 Q2 | -91.51 Million USD | -1.39% |
| 2019 Q3 | -101.97 Million USD | -11.43% |
| 2019 Q1 | -90.26 Million USD | 8.4% |
| 2018 Q4 | -98.54 Million USD | -2.63% |
| 2018 Q1 | -13.01 Million USD | -6.05% |
| 2018 FY | -98.54 Million USD | -702.9% |
| 2018 Q2 | -14.26 Million USD | -9.57% |
| 2018 Q3 | -96.01 Million USD | -573.2% |
| 2017 Q1 | -6.3 Million USD | 12.15% |
| 2017 Q2 | -6.59 Million USD | -4.61% |
| 2017 Q3 | -9.58 Million USD | -45.32% |
| 2017 FY | -12.27 Million USD | -70.96% |
| 2017 Q4 | -12.27 Million USD | -28.0% |
| 2016 FY | -7.17 Million USD | 17.26% |
| 2016 Q3 | -7.26 Million USD | -19.32% |
| 2016 Q2 | -6.09 Million USD | -51.35% |
| 2016 Q1 | -4.02 Million USD | 53.61% |
| 2016 Q4 | -7.17 Million USD | 1.24% |
| 2015 Q4 | -8.67 Million USD | 23.57% |
| 2015 FY | -8.67 Million USD | -8.52% |
| 2015 Q1 | -5.87 Million USD | 26.49% |
| 2015 Q2 | -10.62 Million USD | -80.78% |
| 2015 Q3 | -11.35 Million USD | -6.84% |
| 2014 Q2 | -13.21 Million USD | 16.83% |
| 2014 Q1 | -15.88 Million USD | 10.63% |
| 2014 FY | -7.99 Million USD | 55.02% |
| 2014 Q4 | -7.99 Million USD | 37.54% |
| 2014 Q3 | -12.8 Million USD | 3.1% |
| 2013 Q3 | -17.69 Million USD | -28.02% |
| 2013 Q1 | -12.89 Million USD | 11.11% |
| 2013 FY | -17.77 Million USD | -22.52% |
| 2013 Q4 | -17.77 Million USD | -0.44% |
| 2013 Q2 | -13.82 Million USD | -7.2% |
| 2012 Q2 | -13.44 Million USD | -8.21% |
| 2012 Q3 | -15.7 Million USD | -16.86% |
| 2012 Q4 | -14.5 Million USD | 7.63% |
| 2012 FY | -14.5 Million USD | -18.13% |
| 2012 Q1 | -12.42 Million USD | -1.13% |
| 2011 FY | -12.28 Million USD | -141.66% |
| 2011 Q3 | -12.57 Million USD | -43.13% |
| 2011 Q2 | -8.78 Million USD | -45.22% |
| 2011 Q1 | -6.05 Million USD | -19.05% |
| 2011 Q4 | -12.28 Million USD | 2.34% |
| 2010 FY | -5.08 Million USD | -328.3% |
| 2010 Q4 | -5.08 Million USD | -18.54% |
| 2010 Q1 | -8.21 Million USD | -469.09% |
| 2010 Q2 | -4.48 Million USD | 45.41% |
| 2010 Q3 | -4.28 Million USD | 4.41% |
| 2009 Q1 | 5.03 Million USD | 27.65% |
| 2009 Q2 | 3.45 Million USD | -31.43% |
| 2009 FY | 2.22 Million USD | -43.59% |
| 2009 Q4 | 2.22 Million USD | -25.53% |
| 2009 Q3 | 2.98 Million USD | -13.46% |
| 2008 Q2 | -472 Thousand USD | 88.76% |
| 2008 Q1 | -4.19 Million USD | 8.64% |
| 2008 FY | 3.94 Million USD | 185.86% |
| 2008 Q4 | 3.94 Million USD | 145.25% |
| 2008 Q3 | 1.6 Million USD | 440.89% |
| 2007 Q1 | -976 Thousand USD | 78.31% |
| 2007 FY | -4.59 Million USD | -2.16% |
| 2007 Q4 | -4.59 Million USD | 61.8% |
| 2007 Q3 | -12.03 Million USD | 13.31% |
| 2007 Q2 | -13.88 Million USD | -1322.13% |
| 2006 FY | -4.49 Million USD | 59.22% |
| 2006 Q3 | -6.42 Million USD | 1.97% |
| 2006 Q4 | -4.49 Million USD | 29.99% |
| 2006 Q2 | -6.55 Million USD | 17.84% |
| 2006 Q1 | -7.97 Million USD | 27.68% |
| 2005 Q3 | -13.35 Million USD | -1182.61% |
| 2005 Q1 | -1.56 Million USD | -32.04% |
| 2005 FY | -11.03 Million USD | -832.54% |
| 2005 Q2 | -1.04 Million USD | 33.35% |
| 2005 Q4 | -11.03 Million USD | 17.38% |
| 2004 Q4 | -1.18 Million USD | 86.98% |
| 2004 FY | -1.18 Million USD | 72.72% |
| 2004 Q1 | -2.48 Million USD | 42.8% |
| 2004 Q2 | -11.93 Million USD | -381.29% |
| 2004 Q3 | -9.08 Million USD | 23.9% |
| 2003 FY | -4.33 Million USD | -189.66% |
| 2003 Q4 | -4.33 Million USD | 34.34% |
| 2003 Q3 | -6.6 Million USD | -23.42% |
| 2003 Q2 | -5.35 Million USD | -210.4% |
| 2003 Q1 | 4.84 Million USD | 0.23% |
| 2002 Q3 | 5.69 Million USD | -25.04% |
| 2002 Q2 | 7.59 Million USD | 8.42% |
| 2002 Q1 | 7 Million USD | -4.86% |
| 2002 Q4 | 4.83 Million USD | -15.05% |
| 2002 FY | 4.83 Million USD | -34.32% |
| 2001 FY | 7.36 Million USD | 296.48% |
| 2001 Q1 | 4.45 Million USD | 139.89% |
| 2001 Q2 | 5.59 Million USD | 25.48% |
| 2001 Q4 | 7.36 Million USD | 27.79% |
| 2001 Q3 | 5.76 Million USD | 3.08% |
| 2000 Q3 | 51.77 Thousand USD | -99.7% |
| 2000 FY | 1.85 Million USD | -85.82% |
| 2000 Q1 | 16.71 Million USD | 27.61% |
| 2000 Q4 | 1.85 Million USD | 3486.65% |
| 2000 Q2 | 17.09 Million USD | 2.27% |
| 1999 Q3 | 10.6 Million USD | 23.26% |
| 1999 Q2 | 8.6 Million USD | 4.88% |
| 1999 Q1 | 8.2 Million USD | 7.89% |
| 1999 FY | 13.1 Million USD | 72.37% |
| 1999 Q4 | 13.1 Million USD | 23.58% |
| 1998 FY | 7.6 Million USD | 590.91% |
| 1998 Q3 | 7.5 Million USD | 36.36% |
| 1998 Q4 | 7.6 Million USD | 1.33% |
| 1998 Q1 | 4 Million USD | 263.64% |
| 1998 Q2 | 5.5 Million USD | 37.5% |
| 1997 FY | 1.1 Million USD | -56.0% |
| 1997 Q1 | 2.4 Million USD | -4.0% |
| 1997 Q2 | 2.5 Million USD | 4.17% |
| 1997 Q3 | 1.2 Million USD | -52.0% |
| 1997 Q4 | 1.1 Million USD | -8.33% |
| 1996 Q3 | 2.4 Million USD | 4.35% |
| 1996 Q1 | 2 Million USD | 42.86% |
| 1996 FY | 2.5 Million USD | 78.57% |
| 1996 Q4 | 2.5 Million USD | 4.17% |
| 1996 Q2 | 2.3 Million USD | 15.0% |
| 1995 Q2 | 400 Thousand USD | 180.0% |
| 1995 Q4 | 1.4 Million USD | 0.0% |
| 1995 FY | 1.4 Million USD | 275.0% |
| 1995 Q1 | -500 Thousand USD | 37.5% |
| 1995 Q3 | - USD | -100.0% |
| 1994 Q3 | 300 Thousand USD | -62.5% |
| 1994 Q1 | 600 Thousand USD | 200.0% |
| 1994 Q2 | 800 Thousand USD | 33.33% |
| 1994 FY | -800 Thousand USD | -500.0% |
| 1994 Q4 | -800 Thousand USD | -366.67% |
| 1993 Q2 | - USD | 0.0% |
| 1993 FY | 200 Thousand USD | 122.22% |
| 1993 Q4 | 200 Thousand USD | 100.0% |
| 1993 Q3 | 100 Thousand USD | 0.0% |
| 1992 Q4 | -900 Thousand USD | 0.0% |
| 1992 FY | -900 Thousand USD | 25.0% |
| 1991 Q4 | -1.2 Million USD | 0.0% |
| 1991 Q1 | 1.5 Million USD | -11.76% |
| 1991 FY | -1.2 Million USD | -170.59% |
| 1990 FY | 1.7 Million USD | -85.47% |
| 1990 Q4 | 1.7 Million USD | 0.0% |
| 1989 FY | 11.7 Million USD | 19.39% |
| 1989 Q4 | 11.7 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 5803.371% |
| AngioDynamics, Inc. | -70.14 Million USD | -109.866% |
| AtriCure, Inc. | -9.81 Million USD | -1399.633% |
| Avinger, Inc. | 10.12 Million USD | 1554.585% |
| Azenta, Inc. | -618.47 Million USD | 76.199% |
| BioLife Solutions, Inc. | 7.25 Million USD | 2129.56% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 106.012% |
| Daxor Corporation | 755.65 Thousand USD | 19580.215% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -9913.878% |
| Femasys Inc. | -15.01 Million USD | -880.367% |
| GlucoTrack, Inc. | -4.29 Million USD | -3326.536% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 482.447% |
| Hologic, Inc. | 374.4 Million USD | 139.317% |
| ICU Medical, Inc. | 1.45 Billion USD | 110.149% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 94.467% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -1991.822% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -2745.072% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -3333.372% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -3333.372% |
| Masimo Corporation | 804 Million USD | 118.309% |
| Microbot Medical Inc. | -2.28 Million USD | -6339.37% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | -1434.055% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 148.707% |
| Nephros, Inc. | -2.47 Million USD | -5857.264% |
| NovoCure Limited | 355.42 Million USD | 141.417% |
| NEXGEL, Inc. | 98 Thousand USD | 150308.163% |
| NEXGEL, Inc. | 98 Thousand USD | 150308.163% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 349.266% |
| OraSure Technologies, Inc. | -276.9 Million USD | 46.839% |
| Pro-Dex, Inc. | 10.91 Million USD | 1448.516% |
| Pulse Biosciences, Inc. | -35.22 Million USD | -317.944% |
| Predictive Oncology Inc. | -5.87 Million USD | -2406.946% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 4959.528% |
| QuidelOrtho Corporation | 2.49 Billion USD | 105.899% |
| Repligen Corporation | -39.51 Million USD | -272.489% |
| Sanara MedTech Inc. | 6.64 Million USD | 2315.295% |
| Sharps Technology, Inc. | -3.01 Million USD | -4785.778% |
| Utah Medical Products, Inc. | -92.52 Million USD | -59.095% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 107.491% |
| Jin Medical International Ltd. | -2.81 Million USD | -5126.472% |